New England Private Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $340K | Sell |
3,948
-209
| -5% | -$18K | 0.05% | 127 |
|
2025
Q1 | $337K | Hold |
4,157
| – | – | 0.05% | 112 |
|
2024
Q4 | $374K | Hold |
4,157
| – | – | 0.06% | 109 |
|
2024
Q3 | $411K | Hold |
4,157
| – | – | 0.07% | 104 |
|
2024
Q2 | $385K | Sell |
4,157
-1,000
| -19% | -$92.7K | 0.07% | 102 |
|
2024
Q1 | $506K | Buy |
5,157
+1,209
| +31% | +$119K | 0.09% | 92 |
|
2023
Q4 | $352K | Hold |
3,948
| – | – | 0.07% | 103 |
|
2023
Q3 | $288K | Buy |
3,948
+1
| +0% | +$73 | 0.06% | 100 |
|
2023
Q2 | $328K | Sell |
3,947
-809
| -17% | -$67.3K | 0.07% | 91 |
|
2023
Q1 | $362K | Hold |
4,756
| – | – | 0.07% | 83 |
|
2022
Q4 | $395K | Hold |
4,756
| – | – | 0.08% | 78 |
|
2022
Q3 | $377K | Hold |
4,756
| – | – | 0.09% | 77 |
|
2022
Q2 | $427K | Hold |
4,756
| – | – | 0.08% | 80 |
|
2022
Q1 | $427K | Hold |
4,756
| – | – | 0.08% | 80 |
|
2021
Q4 | $532K | Hold |
4,756
| – | – | 0.09% | 76 |
|
2021
Q3 | $598K | Hold |
4,756
| – | – | 0.11% | 66 |
|
2021
Q2 | $644K | Hold |
4,756
| – | – | 0.12% | 65 |
|
2021
Q1 | $645K | Hold |
4,756
| – | – | 0.11% | 65 |
|
2020
Q4 | $670K | Hold |
4,756
| – | – | 0.15% | 59 |
|
2020
Q3 | $530K | Hold |
4,756
| – | – | 0.13% | 59 |
|
2020
Q2 | $532K | Hold |
4,756
| – | – | 0.15% | 57 |
|
2020
Q1 | $368K | Hold |
4,756
| – | – | 0.13% | 61 |
|
2019
Q4 | $452K | Hold |
4,756
| – | – | 0.12% | 59 |
|
2019
Q3 | $363K | Sell |
4,756
-450
| -9% | -$34.3K | 0.09% | 107 |
|
2019
Q2 | $456K | Sell |
5,206
-1,000
| -16% | -$87.6K | 0.11% | 98 |
|
2019
Q1 | $563K | Buy |
6,206
+1,000
| +19% | +$90.7K | 0.15% | 84 |
|
2018
Q4 | $373K | Hold |
5,206
| – | – | 0.11% | 96 |
|
2018
Q3 | $499K | Sell |
5,206
-1,000
| -16% | -$95.9K | 0.13% | 89 |
|
2018
Q2 | $591K | Buy |
6,206
+1,000
| +19% | +$95.2K | 0.17% | 81 |
|
2018
Q1 | $456K | Buy |
5,206
+453
| +10% | +$39.7K | 0.13% | 93 |
|
2017
Q4 | $403K | Buy |
4,753
+2
| +0% | +$170 | 0.11% | 95 |
|
2017
Q3 | $411K | Buy |
4,751
+2
| +0% | +$173 | 0.12% | 88 |
|
2017
Q2 | $367K | Buy |
4,749
+7
| +0.1% | +$541 | 0.11% | 95 |
|
2017
Q1 | $329K | Buy |
4,742
+1
| +0% | +$69 | 0.11% | 97 |
|
2016
Q4 | $281K | Buy |
4,741
+1
| +0% | +$59 | 0.1% | 98 |
|
2016
Q3 | $314K | Buy |
4,740
+2
| +0% | +$132 | 0.11% | 91 |
|
2016
Q2 | $256K | Sell |
4,738
-1,066
| -18% | -$57.6K | 0.1% | 98 |
|
2016
Q1 | $300K | Sell |
5,804
-3,443
| -37% | -$178K | 0.12% | 88 |
|
2015
Q4 | $649K | Sell |
9,247
-990
| -10% | -$69.5K | 0.26% | 57 |
|
2015
Q3 | $638K | Sell |
10,237
-2,915
| -22% | -$182K | 0.27% | 53 |
|
2015
Q2 | $1.11M | Buy |
13,152
+9,243
| +236% | +$777K | 0.42% | 44 |
|
2015
Q1 | $288K | Buy |
+3,909
| New | +$288K | 0.11% | 78 |
|